Special Issue "Competitive Advantage Strategies for Healthcare Industry"
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Health Care Sciences & Services".
Deadline for manuscript submissions: 31 October 2021.
Interests: healthcare management; medical device industry; digital healthcare; technology commercialization; health policy
Special Issues and Collections in MDPI journals
The healthcare industry is an aggregation and integration of sectors within the economic system that provides goods and services to treat patients with curative, preventive, rehabilitative, and palliative care. It includes the generation and commercialization of goods and services for maintaining and re-establishing health. The modern healthcare industry includes three essential branches, services, products, and finance, and may be divided into many sectors and categories. The industry depends on interdisciplinary teams of trained professionals and paraprofessionals to meet the health needs of individuals and populations.
The main objective of this Special Issue is to advance the fields of the healthcare industry and innovation management. Thus, papers submitted for the Special Issue should empirically or quantitatively address the valuable implications of the healthcare industry.
Dr. Munjae Lee
Dr. Kyu-sung Lee
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- healthcare industry
- medical device industry
- pharmaceutical industry
- digital health
- health management
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: The restructuring of China’s pharmaceutical industry under China’s governmentality
Authors: Woojong Moon
Affiliation: college of nursing, Hanyang University in Korea
Abstract: In China’s national focus on rapid economic growth since its market-oriented transition in the early 1980s, the field of health care and medicine was ignored to a great extent. Various social and health problems emerged accordingly. Against this background, the SARS outbreak occurred in 2002 and finally led China to the health care reform and the restructuring of the pharmaceutical industry. China’s government has exerted its controlling and hegemonic power on the industrial restructuring process. This study examines the Chinese government-led restructuring of the pharmaceutical industry with Foucault’s concept of governmentality. According to Foucault, governmentality is intimately related to power relations and ruling strategy to configure the health, social, and economic lives of individuals and populations in a specific way. I argue that the concept of governmentality can be applied to corporations in a similar way. This study shows that China’s pharmaceutical industrial restructuring has proceeded under the differential governmentality between domestic and foreign pharmaceutical companies and has been strengthened for the Chinese people’ health, China’s desire for the global market, and economic nationalism. In sum, China’s governmentality works on the pharmaceutical industry ultimately for China’s state legitimacy.